Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Entia Biosciences's share price for the quarter that ended in Dec. 2016 was $0.056. Entia Biosciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2016 was 28.15 Mil. Therefore, Entia Biosciences's market cap for the quarter that ended in Dec. 2016 was $1.58 Mil.
Entia Biosciences's quarterly market cap
declined
from Jun. 2016 ($1.41 Mil) to Sep. 2016 ($1.27 Mil) but then
increased
from Sep. 2016 ($1.27 Mil) to Dec. 2016 ($1.58 Mil).
Entia Biosciences's annual market cap
declined
from Dec. 2014 ($3.18 Mil) to Dec. 2015 ($2.53 Mil) and
declined
from Dec. 2015 ($2.53 Mil) to Dec. 2016 ($1.58 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Entia Biosciences's Enterprise Value for Today is $0.01 Mil.
Entia Biosciences (OTCPK:ERGO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Entia Biosciences Market Cap Related Terms
Entia Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Entia Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Entia Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entia Biosciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Entia Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Entia Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Entia Biosciences's Market Cap for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entia Biosciences (ERGO) has a Market Cap of $0.01 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' Market Cap too high?
Entia Biosciences' current Market Cap is $0.01 Mil. The Biotechnology industry median Market Cap is 119.57. Entia Biosciences' value of $0.01 Mil is 100% below this industry median.
How does Entia Biosciences' Market Cap compare to OBMP and NSPX?
Entia Biosciences' Market Cap of $0.01 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 119.57. Entia Biosciences' value of $0.01 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.57, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entia Biosciences's current Market Cap of $0.01 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Entia Biosciences and its competitors. For the Biotechnology industry, the median Market Cap is 119.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entia Biosciences's current Market Cap is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current Market Cap of $0.01 Mil. The current Market Cap is $0.01 Mil and 100% below the Biotechnology industry median of 119.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current Market Cap is $0.01 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERGO has been successfully added to your 